EUVIMEDEUVIMED entdecken
Crossref

68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging

Tukang Peng iD, Chao Wang, Jun Wen, Qingyu Zhang, Cheng Wang, Chun Lv, Fuqiang Du, Zhoumi Hu, Tao Xu, Gang Huang, Jianjun Liu iD, Haitao Zhao iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Tukang Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongf…. Hauptthemen laut MEDLINE: Gallium Radioisotopes, CD8-Positive T-Lymphocytes, Single-Domain Antibodies, Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Shanghai Jiao Tong University, National Key Research and Development Program of China, Innovative Research Team of High-level Local University in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 68Ga-labeled nanobody SNA006 marks a significant advancement in noninvasive immunoPET imaging of CD8+ T cells, facilitating real-time tracking of cellular immune responses in cancer, yet its pharmacokinetic properties remain suboptimal. This study aimed to develop a next-generation CD8-targeting immunoPET nanobody probe by incorporating a PEGylated brush border membrane enzyme-cleavable linker to improve pharmacokinetics and to evaluate its characterization in CD8-positive intrapulmonary tumors. A precursor based on SNA006, containing a PEGylated brush border membrane enzyme-cleavable linker, was designed, synthesized, and radiolabeled with gallium-68 to yield 68Ga-NOTA-m-SNA006. The probe was subsequently assessed both in vitro and in vivo. The probe exhibited high radiochemical yield, purity, and favorable stability, and demonstrated binding to the CD8 protein with high affinity. PET/CT imaging and biodistribution studies revealed that 68Ga-NOTA-m-SNA006 exhibited favorable pharmacokinetic properties, including rapid clearance from the kidneys, reduced liver uptake, and sustained retention in the tumor, compared with 68Ga-NODAGA-SNA006. 68Ga-NOTA-m-SNA006 exhibited high uptake in lung lesions during in vivo PET imaging, reflecting CD8 expression in an intrapulmonary tumor model. In summary, we present a novel 68Ga-labeled SNA006 radiotracer with an optimized linker moiety, 68Ga-NOTA-m-SNA006, which effectively decreases renal and hepatic uptake while maintaining tumor uptake, thereby enhancing the tumor-to-background ratio. This approach represents a critical advancement in addressing the persistent challenge of radioactivity in the kidneys and liver associated with nanobody-based radiopharmaceuticals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesCD8-Positive T-LymphocytesSingle-Domain AntibodiesLiverKidneyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsHeterocyclic CompoundsAnimalsMiceTissue DistributionHumansCell Line, TumorHeterocyclic Compounds, 1-RingFemaleLung NeoplasmsPositron-Emission Tomography

Stichwörter der Autor:innen

CD8PEGylationcleavable linkergallium-68immunoPETnanobody

Substanzen

Gallium RadioisotopesSingle-Domain AntibodiesRadiopharmaceuticalsHeterocyclic Compounds, 1-RingHeterocyclic CompoundsGallium-681,4,7-triazacyclononane-N,N',N''-triacetic acid

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Rd, Shanghai 200127, China.
  • SmartNuclide Biopharma Co. Ltd., 218 Xinghu St., BioBAY A4-202, Suzhou Industrial Park, Suzhou 215123, China.
  • College of Chemistry and Materials Science, Shanghai Normal University, Shanghai 210000, China.
  • Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.

ORCID-Profile: Tukang Peng, Jianjun Liu, Haitao Zhao

Förderung

  • Shanghai Jiao Tong University
  • National Key Research and Development Program of China
  • Innovative Research Team of High-level Local University in Shanghai
  • National Natural Science Foundation of China

Zitieren

APA

Peng, T., Wang, C., Wen, J., Zhang, Q., Wang, C., Lv, C., Du, F., Hu, Z., Xu, T., Huang, G., Liu, J., & Zhao, H. (2025). 68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00041

Vancouver

Peng T, Wang C, Wen J, Zhang Q, Wang C, Lv C, et al. 68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00041

BibTeX
@article{Peng2025,
  author = {Peng, Tukang and Wang, Chao and Wen, Jun and Zhang, Qingyu and Wang, Cheng and Lv, Chun and Du, Fuqiang and Hu, Zhoumi and Xu, Tao and Huang, Gang and Liu, Jianjun and Zhao, Haitao},
  title = {68 Ga-NOTA-m-SNA006: A Next-Generation CD8-Targeting Nanobody Probe to Enhance Renal and Hepatic Clearance in Noninvasive ImmunoPET Imaging},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00041}
}
Kostenlos starten →